Whoop, which makes fitness trackers and provides performance metrics for athletes, raises $100M at a $1.2B valuation
- Golfer Nick Watney sought a Covid test based on Whoop data — Boston startup raises $100 million, IVP's Liaw joins board — Whoop, the maker of a wearable device …
Context & Ripple Effects
This $100M round is the third step in Whoop's rapid funding ladder — a $25M Series C in 2018 and a $55M Series D a year later had already pushed it past $100M raised, and the $1.2B valuation here more than doubles the prior trajectory's pace. The Covid hook is concrete: golfer Nick Watney sought a test based on Whoop's data, giving the Boston startup a public proof point for its performance metrics as health monitoring.
The raise also sets up the round that followed: SoftBank's Vision Fund 2 came in at a $3.6B valuation less than a year later, and by 2026 Whoop was raising $575M at $10.1B with a reported $1B in ARR and IPO preparations underway.
First-order effects
- IVP's Liaw joins the board, adding an institutional growth investor at the exact moment Covid-driven demand for physiological monitoring is validating Whoop's subscription model.
- The $100M extends Whoop's runway to scale its screenless band and coaching subscription while consumer interest in health data is at a peak.
Second-order effects
- The valuation jump from this round into SoftBank's $3.6B bet forced rivals — most directly Oura — into their own capital raises, setting up the parallel Oura-Whoop IPO race investors later greeted cautiously.
- Whoop's subscription-first economics, rather than one-time hardware sales, became the template its competitors had to answer to avoid Fitbit's low-margin hardware trap.
Third-order effects
- If the pattern holds, consumer wearables consolidate around subscription-revenue platforms heading for public listings — the 75% staff expansion and IPO preparation in 2026 is the endpoint this 2020 round set in motion.
- The Covid era permanently repositioned fitness trackers as health-monitoring infrastructure, which is what later justified Whoop's push into clinician consultations and health records.
The trend: Consumer health wearables are scaling from athlete gadgets into subscription-based health platforms, with funding cadence and IPO timing set by the Oura-Whoop race.